Publications by authors named "Tzu-Sheng Cheng"

Claim this Profile
R
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.
Po-Yao Hsu, Tzu-Sheng Cheng, Shih-Chang Chuang, Wen-Tsan Chang, Po-Cheng Liang, Cheng-Ting Hsu

Cancer Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C patients with genotype-2 infection after completed treatment.
Tzu-Sheng Cheng, Po-Cheng Liang, Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang

Kaohsiung J Med Sci· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis